Title : Discovery of highly potent and selective EGFRT790M/L858R TKIs against NSCLC based on molecular dynamic simulation.

Pub. Date : 2022 Jan 15

PMID : 34794818






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The third-generation EGFR tyrosine kinase inhibitors (TKIs) Rociletinib and Osimertinib (AZD9291) achieved remarkable clinical efficacy. osimertinib epidermal growth factor receptor Homo sapiens